Dear Colleagues,

The vaccination era is a major global public health milestone that has led to the eradication of and reduction in infectious diseases. Vaccination has been important in reducing Hepatitis A and B cases in younger age groups in the context of viral hepatitis. In addition, vaccination against HBV, associated with immunoglobulin and prophylactic antiviral use, has led to a 90% reduction in cases of mother-to-child transmission and has also helped preventing Hepatitis D infection. As for the hepatitis C virus, despite the unavailability of a vaccine, the use of antiviral treatments has been promising and several studies for the development of an effective vaccine have been conducted.  Vaccination against hepatitis E is only licensed in China, and more safety studies in children, the elderly, and other special populations are needed for future global deployment. This Special Issue aims to receive original research papers and reviews that provide updates in vaccination and treatment for viral hepatitis, with research in the following areas: vaccination coverage in the general population and vulnerable populations; new vaccines and treatments, vaccine development, and evaluation; studies in immune scape and immune response; and other studies that fit the Issue's theme.

We look forward to receiving your contributions.

Dr. Bárbara Vieira Do Lago
Dr. Vinicius M. Mello
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• vaccination
• treatments
• viral hepatitis
• hepatitis A
• hepatitis B
• hepatitis C
• hepatitis D
• hepatitis E